Turn Therapeutics Inc. (NASDAQ:TTRX) saw its shares soar by 134.29% after the market closed on Wednesday, closing at $16.40.
Check out the current price of TTRX stock here.
Nasdaq Listing
The clinical-stage biotechnology company commenced trading on the Nasdaq Capital Market on Wednesday.
Nasdaq Exchange welcomed the company on social media, calling it a company “paving the way in pharmaceutical technologies that heal, not just manage.”
The Securities and Exchange Commission (SEC) declared Turn’s registration statement on Form S-1 effective Sept. 30.
See Also: Tempus AI Executive Ryan Fukushima Sells $460,000 Worth Of Stock
Bradley Burnham, founder and CEO, stated during the ceremony the company was “built on a shoestring, with an absolute disdain for waste,” emphasizing their lean operating model.
Closing Bell Ceremony
Turn Therapeutics participated in the closing bell ceremony at 4 p.m. Eastern Time Wednesday, broadcast live from Nasdaq's MarketSite in New York.
Company Profile
The California-based biotech develops next-generation dermatology, wound care, and anti-infective therapies.
Clear Street LLC handled the financial advisory role, and Davis, Polk, and Wardwell provided legal counsel for the listing.
Price Action: According to Benzinga Pro data, on Wednesday, TTRX fell 26.47% during regular trading to close at $7.00.
Benzinga Edge Stock Rankings indicate that TTRX has a negative price trend across all time frames. Track the performance of other players in this segment.
Read Next:
Photo Courtesy: Miha Creative on Shutterstock.com
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
